Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease

Chu Wan Lee, Yao Hsiang Shih, Yu-Min Kuo

研究成果: Review article

19 引文 (Scopus)

摘要

Accumulation, aggregation and deposition of the amyloid-β (Aβ) peptides in the brain are widely accepted as the central events in the pathogenesis of Alzheimer's disease (AD). Any factor that is capable of causing these events is potentially a risk factor for AD. In the last decade, evidence has accumulated to support the association between cerebral vascular diseases (CVD) and AD. CVD is known to induce amyloid deposition and affects the age of onset for sporadic AD; whereas, amyloid deposition has been shown to cause cerebrovascular degeneration. In this review, we propose a positive feedback loop between CVD and amyloid deposition. The disease cycle could be triggered by aging and/or other environmental factor-associated CVD, as in late-onset sporadic AD patients, or by over production of Aβ, as in the familial AD patients and amyloid precursor protein transgenic animals.

原文English
頁(從 - 到)4-10
頁數7
期刊Current Alzheimer research
11
發行號1
DOIs
出版狀態Published - 2014 一月 13

指紋

Amyloid Plaques
Alzheimer Disease
Pathology
Vascular Diseases
Amyloid
Genetically Modified Animals
Amyloid beta-Protein Precursor
Age of Onset
Peptides
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

引用此文

Lee, Chu Wan ; Shih, Yao Hsiang ; Kuo, Yu-Min. / Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease. 於: Current Alzheimer research. 2014 ; 卷 11, 編號 1. 頁 4-10.
@article{cebb9b4a20a6439688865a1d3f4c0029,
title = "Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease",
abstract = "Accumulation, aggregation and deposition of the amyloid-β (Aβ) peptides in the brain are widely accepted as the central events in the pathogenesis of Alzheimer's disease (AD). Any factor that is capable of causing these events is potentially a risk factor for AD. In the last decade, evidence has accumulated to support the association between cerebral vascular diseases (CVD) and AD. CVD is known to induce amyloid deposition and affects the age of onset for sporadic AD; whereas, amyloid deposition has been shown to cause cerebrovascular degeneration. In this review, we propose a positive feedback loop between CVD and amyloid deposition. The disease cycle could be triggered by aging and/or other environmental factor-associated CVD, as in late-onset sporadic AD patients, or by over production of Aβ, as in the familial AD patients and amyloid precursor protein transgenic animals.",
author = "Lee, {Chu Wan} and Shih, {Yao Hsiang} and Yu-Min Kuo",
year = "2014",
month = "1",
day = "13",
doi = "10.2174/1567205010666131119234308",
language = "English",
volume = "11",
pages = "4--10",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease. / Lee, Chu Wan; Shih, Yao Hsiang; Kuo, Yu-Min.

於: Current Alzheimer research, 卷 11, 編號 1, 13.01.2014, p. 4-10.

研究成果: Review article

TY - JOUR

T1 - Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease

AU - Lee, Chu Wan

AU - Shih, Yao Hsiang

AU - Kuo, Yu-Min

PY - 2014/1/13

Y1 - 2014/1/13

N2 - Accumulation, aggregation and deposition of the amyloid-β (Aβ) peptides in the brain are widely accepted as the central events in the pathogenesis of Alzheimer's disease (AD). Any factor that is capable of causing these events is potentially a risk factor for AD. In the last decade, evidence has accumulated to support the association between cerebral vascular diseases (CVD) and AD. CVD is known to induce amyloid deposition and affects the age of onset for sporadic AD; whereas, amyloid deposition has been shown to cause cerebrovascular degeneration. In this review, we propose a positive feedback loop between CVD and amyloid deposition. The disease cycle could be triggered by aging and/or other environmental factor-associated CVD, as in late-onset sporadic AD patients, or by over production of Aβ, as in the familial AD patients and amyloid precursor protein transgenic animals.

AB - Accumulation, aggregation and deposition of the amyloid-β (Aβ) peptides in the brain are widely accepted as the central events in the pathogenesis of Alzheimer's disease (AD). Any factor that is capable of causing these events is potentially a risk factor for AD. In the last decade, evidence has accumulated to support the association between cerebral vascular diseases (CVD) and AD. CVD is known to induce amyloid deposition and affects the age of onset for sporadic AD; whereas, amyloid deposition has been shown to cause cerebrovascular degeneration. In this review, we propose a positive feedback loop between CVD and amyloid deposition. The disease cycle could be triggered by aging and/or other environmental factor-associated CVD, as in late-onset sporadic AD patients, or by over production of Aβ, as in the familial AD patients and amyloid precursor protein transgenic animals.

UR - http://www.scopus.com/inward/record.url?scp=84891818678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891818678&partnerID=8YFLogxK

U2 - 10.2174/1567205010666131119234308

DO - 10.2174/1567205010666131119234308

M3 - Review article

C2 - 24251391

AN - SCOPUS:84891818678

VL - 11

SP - 4

EP - 10

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 1

ER -